Marcos Jessé Abrahão Silva | Cell Biology | Best Researcher Award

Published on by Cell Biologist

Mr. Marcos Jessé Abrahão Silva | Cell Biology | Best Researcher Award

Mr. Marcos Jessé Abrahão Silva, State University of Pará (UEPA), Brazil

Marcos Jessé Abrahão Silva is a Brazilian biomedical scientist and Ph.D. student at the State University of Pará (UEPA), specializing in immunogenetics and molecular biology. He holds a Bachelor’s in Biomedicine from UNAMA and a Master’s in Epidemiology and Health Surveillance from the Evandro Chagas Institute. Marcos has contributed to over 35 technical-scientific publications, including high-impact journals such as Frontiers in Immunology and Microorganisms, and has accumulated more than 260 citations. He’s a published author of multiple scientific books and a reviewer for prestigious journals like Current Microbiology. His research spans infectious diseases like COVID-19, leprosy, HIV, and bacterial resistance. As a member of Sigma Xi, his academic dedication has earned him editorial appointments and international collaborations, including with Tulane University. Currently, Marcos leads research on HIV prevention in vulnerable groups using innovative approaches via social media under the project “raprev.aids”.

Publication Profile:

Google Scholar

✅ Strengths for the Award:

  1. Strong Publication Record 📚
    Marcos has authored or co-authored over 35 scientific publications, with more than 20 in high-impact journals (JCR indexed) such as Frontiers in Immunology, Viruses, Microorganisms, and Genes—an exceptional record for a Ph.D. student.

  2. Global Citation Impact 🌍
    His Google Scholar h-index of 7, Scopus h-index of 7, and Web of Science h-index of 6—along with 260+ citations—reflect international academic recognition and influence.

  3. Multidisciplinary Research Expertise 🧬
    His work integrates epidemiology, immunogenetics, molecular biology, and bioinformatics, focusing on infectious diseases including COVID-19, HIV, leprosy, and paracoccidioidomycosis, which are highly relevant to global health.

  4. Editorial and Peer-Review Roles ✍️
    Marcos is a reviewer for top journals, including CURRENT MICROBIOLOGY, and serves on the editorial board of the International Journal of Genetics—demonstrating leadership in academic publishing.

  5. International and Institutional Collaboration 🤝
    He collaborates with respected institutions like Evandro Chagas Institute, Federal University of Ceará, and Tulane University, expanding the impact of his research across borders.

  6. Innovation in Health Communication 💡
    He is currently leading a social innovation project (raprev.aids) combining science, technology, and culture for HIV prevention among vulnerable populations using digital and artistic media—a model for translational science.

⚠️ Areas for Improvement:

  1. First-Author Leadership in Top-Tier Journals
    While co-authorship is strong, more consistent first-author publications in Q1 journals would further solidify his leadership in research.

  2. Patent Contributions & Industry Linkages
    Although experienced in academic research, strengthening links with biomedical industry or technology transfer (patents) could amplify his societal and commercial impact.

  3. Global Networking
    Participation in more international conferences or fellowships would further raise his visibility on the global scientific stage.

🎓 Education0:

Marcos Jessé Abrahão Silva’s academic foundation is rooted in Biomedicine, having completed his Bachelor’s degree at the University of the Amazon (UNAMA) from 2018 to 2021. Following this, he earned his Master of Science degree from the prestigious Evandro Chagas Institute (IEC) through the Postgraduate Program in Epidemiology and Health Surveillance (2021–2023). He is currently pursuing his Ph.D. in Parasitology Biology in the Amazon at the State University of Pará (UEPA). Additionally, he is specializing in Bioinformatics at the Federal Technological University of Paraná (UTFPR), expected to complete in 2025. His educational trajectory reflects a strong emphasis on translational research, infectious disease epidemiology, and molecular diagnostics. Marcos has also been inducted as an official member of Sigma Xi, The Scientific Research Honor Society, highlighting his academic and professional distinction. His interdisciplinary education supports his work in cutting-edge biomedical and public health research.

🧪 Experience:

Marcos Jessé has developed extensive research experience in immunogenetics, molecular biology, and epidemiology. He has actively participated in significant research projects, such as the Hansen’s Immunogenetic Study and COVID-19 response analysis in Brazil. Marcos has co-authored more than 35 scientific publications, including international peer-reviewed journals, and written chapters in academic books on infectious diseases. His roles have included principal investigator, project member, and scientific reviewer for journals like Current Microbiology. He also has experience in scientific consulting and is involved in translational research, particularly focusing on disease susceptibility genetics. Marcos collaborates with leading institutions like the Evandro Chagas Institute, Federal University of Ceará, and Tulane University. Beyond academic research, he contributes to community-based health innovation through HIV prevention projects involving social media outreach. He has served in editorial roles and has been recognized with international awards for his scientific contributions, making him a standout emerging researcher from the Global South.

🔍 Research Focus:

Marcos Jessé Abrahão Silva’s research centers on immunogenetics, infectious diseases, and molecular biology, with a special emphasis on diseases endemic to Brazil and the Amazon. He investigates the genetic factors influencing susceptibility to pathogens like Mycobacterium leprae, HIV-1, and SARS-CoV-2, often analyzing Single Nucleotide Polymorphisms (SNPs) and immune response mechanisms. His work aims to unravel how innate and adaptive immune pathways contribute to disease severity, particularly in viral and bacterial infections. Marcos has conducted systematic reviews and meta-analyses to clarify the epidemiological role of genetic polymorphisms. His recent focus includes a culturally innovative HIV prevention project, “raprev.aids,” integrating artistic and scientific communication via social networks. He is also active in studying antimicrobial resistance, such as in Pseudomonas aeruginosa. His research goal is to bridge laboratory science with public health practice, particularly in vulnerable populations across the Amazon and broader Latin America.

📚 Publications Top Notes:

  1. 🧫 Hyperinflammatory response in COVID-19: a systematic review – Viruses

  2. 🧠 Adaptive immunity to SARS-CoV-2 infection: A systematic review – Frontiers in Immunology

  3. 🧬 Innate immunity to SARS-CoV-2 infection: a review – Epidemiology & Infection

  4. 🧪 The Relationship between TLR3 rs3775291 Polymorphism and Infectious Diseases: A Meta-Analysis – Genes

  5. 🧫 The Association between CCL5/RANTES SNPs and Susceptibility to HIV-1 Infection: A Meta-Analysis – Viruses

  6. 🧬 The relationship between 896A/G (rs4986790) polymorphism of TLR4 and infectious diseases: A meta-analysis – Frontiers in Genetics

  7. 🦠 Endemic High-Risk Clone ST277 & SPM-1-Producing P. aeruginosa During COVID-19 in Brazil – Microorganisms

  8. 🧫 Prevalence of MβL-Producing P. aeruginosa in Brazil: A Meta-Analysis – Microorganisms

  9. 🐀 The Presence of Mycobacterium leprae in Wild Rodents – Microorganisms

  10. 🧬 Associations between TLR3 SNPs and COVID-19 in Belém-PA Professionals – Frontiers in Cellular and Infection Microbiology

🔍 Conclusion:

Marcos Jessé Abrahão Silva is an exceptionally promising early-career researcher whose contributions already surpass many peers at the same academic stage. His proven scientific output, international citation record, and commitment to public health innovation make him highly suitable for the Best Researcher Award. His research not only addresses local health challenges in the Amazon and Brazil but also contributes meaningfully to the global understanding of infectious diseases and immune responses.

Yang Gao | Cell Differentiation Processes | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Yang Gao | Cell Differentiation Processes | Best Researcher Award

Prof. Dr. Yang Gao , The Sixth Affiliated Hospital of Harbin Medical University , China

Professor Yang Gao is the Chief Physician and Director of the Critical Care Medicine Department at The Sixth Affiliated Hospital of Harbin Medical University, China. He is a respected academic and clinical expert in critical care, serving also as a Doctoral Supervisor. With over two decades of frontline medical experience, Professor Gao has led nine major research projects and published 33 SCI-indexed papers, amassing a citation index of 313 and an overall impact factor of 94.493. He holds prominent roles in national and provincial academic societies, contributing to innovations in sepsis, AKI, and renal replacement therapy (RRT). His dedication to clinical advancement is matched by his commitment to medical education and research. Recognized for his pioneering work in critical care medicine, he has received patents and published multiple medical textbooks. His leadership, extensive research contributions, and continued impact on critical care practices make him a strong candidate for the Best Researcher Award.

Publication Profile:

Scopus

✅ Strengths for the Award:

  1. Extensive Clinical & Research Expertise: With over two decades in frontline critical care, Professor Gao combines clinical acumen with deep research insight, particularly in sepsis-associated acute kidney injury (AKI) and continuous renal replacement therapy (RRT).

  2. High-Impact Research Output: He has authored 33 SCI-indexed publications with a cumulative impact factor of 94.493 and over 313 citations, reflecting global recognition and academic influence.

  3. Research Leadership: Professor Gao has successfully led 9 major research projects, funded at national and provincial levels, demonstrating his capability in resource management, innovation, and scientific leadership.

  4. Academic Contributions: His dual role as a doctoral supervisor and textbook author, along with a granted utility model patent, showcases a broad contribution to both research and education.

  5. Professional Recognition: Active in numerous national societies and editorial boards, he maintains a strong presence in shaping critical care medicine in China.

🔍 Areas for Improvement:

  • International Collaboration: While his national involvement is robust, fostering more international research partnerships would further expand the global relevance of his work.

  • Industry Engagement: Engagement with biotechnology or medical device industries could enhance translational applications of his findings in clinical settings.

🎓 Education:

Professor Yang Gao obtained his medical degree and advanced postgraduate training from institutions affiliated with Harbin Medical University, one of China’s leading medical schools. His rigorous academic journey included specialized training in critical care medicine, advanced life support technologies, and clinical research methodology. During his doctoral studies, he focused on critical illness mechanisms, with an emphasis on sepsis-associated acute kidney injury (AKI). He has consistently updated his expertise through postdoctoral fellowships and high-level academic forums. Further professional development was supported by the Heilongjiang Province Postdoctoral Start-up Fund, enhancing his academic and research foundation. Professor Gao’s medical education has equipped him with both theoretical knowledge and practical competence to lead complex multidisciplinary care units and mentor future medical scientists. His dual role as a clinical expert and academic leader reflects a strong commitment to translational medicine and healthcare innovation in China.

🏥 Experience:

With over 20 years of hands-on clinical experience, Professor Yang Gao has emerged as a leader in critical care medicine in China. Since 2003, he has been managing critically ill patients, mastering life-saving interventions such as non-invasive/invasive ventilation, blood purification, and continuous renal replacement therapy (CRRT). He is the Director of the Critical Care Medicine Department at The Sixth Affiliated Hospital of Harbin Medical University and holds teaching and supervisory roles for doctoral students. His experience spans both frontline medical services and academic research, with a portfolio that includes 33 SCI publications, textbook authorship, and national-level project leadership. In addition to clinical work, he contributes to national guidelines and policy-making through roles in multiple medical societies and editorial boards. Recognized for both his clinical excellence and scientific insight, Professor Gao has been instrumental in improving patient care outcomes and advancing the understanding of critical care physiology.

🔬 Research Focus:

Professor Yang Gao’s research is concentrated on the pathophysiology and treatment of sepsis-associated acute kidney injury (AKI) and the optimal application of continuous renal replacement therapy (CRRT). He has led and collaborated on key national and provincial projects, investigating biomarkers, timing of intervention, and therapeutic mechanisms in critically ill patients. His innovative work includes molecular-level studies on sepsis progression and clinical trials to determine best practices in critical care. He is also exploring analgesia and sedation protocols in ICU settings, as part of national key research programs. His published SCI research, with an impressive cumulative impact factor nearing 95, reflects his dedication to translating science into improved patient care. Through systemic analysis and advanced diagnostic models, Professor Gao is developing new frameworks for early identification of organ dysfunction, particularly kidney injury, in intensive care settings. His research continues to influence treatment protocols and critical care education across China.

📚 Publications Top Notes:

  1. 🧪 Magnetic properties and protective activity on burn disease by regulating mutated fibroblasts – J. Solid State Chem (2021)

  2. 🧫 Role of IL-10 and TNF-α in Sepsis-Induced AKI – Front. Immunol

  3. 🩺 Timing of CRRT in Septic Shock Patients with AKI – Crit Care Med

  4. 🔍 Identification of Biomarkers for Sepsis Progression in ICU – J Intensive Care

  5. 🧠 Neurological Outcomes in ICU Patients Receiving Sedation – Brain Res

  6. 🦠 MicroRNA Profiling in Sepsis-Induced Kidney Damage – Mol Med Rep

  7. 🧬 Effects of Early CRRT on Inflammatory Mediators – Cytokine

  8. 🧴 Pharmacokinetics of Antibiotics in CRRT Patients – Ther Drug Monit

  9. 🧍‍♂️ Prognostic Value of Serum NGAL in AKI Patients – Am J Nephrol

  10. 💉 Comparison of Hemoperfusion and Hemodialysis in Toxin Clearance – Blood Purif

🧾 Conclusion:

Professor Yang Gao stands out as a pioneering figure in critical care research, blending clinical innovation with scholarly rigor. His sustained contributions to understanding and treating sepsis and AKI, along with his strong academic leadership, make him eminently suitable for the Best Researcher Award. Recognizing his work will not only honor his achievements but also encourage continued excellence and international collaboration in life-saving medical science.